Bi-allelic variants in BOLA3 cause MMDS type 2 with hyperglycinemia (MMDS2; MIM#614299), typically characterized by infantile encephalopathy, leukodystrophy, lactic acidosis, nonketotic hyperglycinemia and death in early childhood [5,7,11]. Here, BOLA3 is linked to Infantile encephalopathy.